Medicare Enrolled

Dr. Suzanne Marshall, PA-C

Medical Physician Assistant · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
12755 WOODFOREST BLVD, Houston, TX 77015
7134551306
In practice since 2011 (14 years)
NPI: 1053696468 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marshall from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marshall? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marshall

Dr. Suzanne Marshall is a medical physician assistant in Houston, TX, with 14 years in practice. Based on federal Medicare data, Dr. Marshall performed 3,692 Medicare services across 1,944 unique beneficiaries.

Between the years covered by Open Payments, Dr. Marshall received a total of $4,020 from 35 pharmaceutical and/or device companies across 229 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marshall is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ Top 3% volume in TX$ $4,020 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,692
Medicare services
Top 3% in TX for medical physician assistant
1,944
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~264 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)386$78$150
Blood draw (venipuncture)296$8$10
Basic metabolic blood panel274$8$10
Liver function blood test panel249$8$15
Lipid panel (cholesterol and triglycerides)234$13$15
Creatinine test (kidney function)198$5$6
Hemoglobin A1c test (diabetes monitoring)183$10$15
Thyroid stimulating hormone (TSH) test168$16$20
Urine microalbumin (protein) analysis163$6$6
Complete blood count (CBC) with differential135$8$10
Vitamin D level test132$29$37
Free thyroxine (T4) test114$9$15
Vitamin B-12 level test85$15$20
Drug injection, under skin or into muscle80$9$24
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes79$21$28
Annual depression screening77$15$19
Annual wellness visit, follow-up76$105$123
Office visit, established patient (20-29 min)71$55$125
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg61$1$20
Office visit, established patient, complex (40-54 min)56$100$200
Electrocardiogram (EKG), 12-lead46$9$20
Testing for presence of drug, read by direct observation45$12$13
Uric acid level test45$4$7
Folic acid level test42$14$20
Urinalysis, manual40$3$24
C-reactive protein test (inflammation marker)40$5$8
Iron level test39$6$10
Iron binding capacity test39$9$10
Parathyroid hormone level test38$40$46
PSA test (prostate cancer screening)36$18$25
Flu vaccine administration36$29$30
Automated urinalysis35$2$3
Flu vaccine, high-dose35$71$74
Face-to-face behavioral counseling for obesity, 15 minutes25$21$26
Chest X-ray, 2 views18$17$35
Test to measure expiratory airflow and volume16$16$40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,020
Total received (2021-2024)
Avg $1,005/year across 4 years
Top 14% in TX for medical physician assistant
35
Companies
229
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,905 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$115 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$957
2023
$1,080
2022
$1,119
2021
$863

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$958
ABBVIE INC.
$812
Dexcom, Inc.
$290
Boehringer Ingelheim Pharmaceuticals, Inc.
$187
Lilly USA, LLC
$172
Janssen Pharmaceuticals, Inc
$163
Bayer HealthCare Pharmaceuticals Inc.
$160
GlaxoSmithKline, LLC.
$152
Astellas Pharma US Inc
$143
Amarin Pharma Inc.
$110
PFIZER INC.
$109
Esperion Therapeutics, Inc.
$101
Takeda Pharmaceuticals U.S.A., Inc.
$95
Antares Pharma, Inc.
$64
Phathom Pharmaceuticals, Inc.
$47
Merck Sharp & Dohme Corporation
$45
AstraZeneca Pharmaceuticals LP
$41
Genentech USA, Inc.
$41
COLOPLAST CORP
$30
Novartis Pharmaceuticals Corporation
$29
Kowa Pharmaceuticals America, Inc.
$26
HeartFlow, Inc.
$23
Abbott Laboratories
$22
AbbVie Inc.
$21
Nestle HealthCare Nutrition Inc.
$20
Amgen Inc.
$18
Ultragenyx Pharmaceutical Inc.
$17
DEXCOM, INC.
$17
Azurity Pharmaceuticals, Inc.
$17
Axsome Therapeutics, Inc.
$17
AIMMUNE THERAPEUTICS, INC.
$16
Nevro Corp.
$16
Eisai Inc.
$15
Merck Sharp & Dohme LLC
$14
Supernus Pharmaceuticals, Inc.
$14
Top 3 companies account for 51.2% of total payments
Associated products mentioned in payments ›
AREXVY · Auvelity · BELSOMRA · BOOSTRIX · BOTOX · BREZTRI · Crysvita · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dayvigo · Dexcom G6 Transmitter · EMGALITY · ENHERTU · ENTRESTO · FFRct · GARDASIL · GARDASIL 9 · HORIZANT · INVEGA SUSTENNA · JARDIANCE · Kerendia · LINZESS · Livalo · MOUNJARO · Myrbetriq · NEXLETOL · NOCDURNA · Otezla · Ozempic · PREVNAR 13 · PREVNAR 20 · PROCLAIM · QULIPTA · RYBELSUS · Restorelle · Rybelsus · SHINGRIX · SYNTHROID · Saxenda · Senza · TLANDO · TRELEGY ELLIPTA · TRINTELLIX · UBRELVY · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Wegovy · XARELTO · Xofluza · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $109 per 100 Medicare services performed
Looking for a medical physician assistant in Houston?
Compare medical physician assistants in the Houston area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical Physician Assistants within 10 mi
325
Per 100K population
6.8
County median income
$73,104
Nearest hospital
AD HOSPITAL EAST, LLC
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Marshall is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 14%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Marshall experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Marshall performed 386 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marshall receive payments from pharmaceutical companies?
Yes. Dr. Marshall received a total of $4,020 from 35 companies across 229 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marshall's costs compare to other medical physician assistants in Houston?
Dr. Marshall's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marshall) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →